Category: Pharmaceutical

Demand for Glucose Monitoring Devices will Grow at a Healthy 3.5% Value CAGR By 2026

Post author By administrator
Post date August 12, 2021

Fact.MR, in its latest market study, opines that the Sales of home diagnostics will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026.

Companies in the Home Diagnostics Market are facing issues in keeping their production facilities fully functional due to shortage of staff and resources amidst the COVID-19 (Coronavirus) outbreak. Get a hands-on over key drivers and threats to the Home Diagnostics Market to make your company future-ready post the pandemic. Avails out reports for exciting prices to learn new opportunities that companies can capitalize on during and after the Coronavirus crisis.

For detailed insights on enhancing your product footprint, request a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

Fact.MR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026. According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market. The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.

Increasing preference for self-diagnosis continues to be a trigger for home diagnostics sales, whereas a combination of industry-specific and regulatory factors continue to influence the strategies of market players. Governing bodies such as the U.S. Food and Drug Administration (FDA) and the European Commission regulate home diagnostics with stringent quality control regulations and labeling requirements.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=1892

Market Segmentation:

By Test Type

Glucose Monitoring Devices
Pregnancy Test
HIV Test Kits
Ovulation Predictor Test Kits
Cholesterol Detection Test Kits
Drug of Abuse Test Kits

By Form

Cassettes
Strips
Midstream
Digital Monitoring
Instruments
Test
Dip Cards

By Regional Market and Country-wise Segmentation

North America
USA
Latin America
Europe
France
Asia Pacific
Middle East
Africa
China

By Distribution Channel

Retail Pharmacies
Drug Stores
Hypermarkets / Supermarkets
Online Pharmacies

For instance, Abbott Laboratories, a leading pharmaceutical company in the U.S., recently got an FDA approval for marketing its FreeStyle^® Libre 14 day Flash Glucose Monitoring system in the U.S. ACON Laboratories, another prominent player in the home diagnostics market announced that it has received FDA clearance of Mission^® U120 urine reagent strips. According to the report, compliance to ever-evolving regulations and gaining regulatory approval remains both an opportunity and challenge for market players.

home diagnostics market 1

The Fact.MR study finds that glucose monitoring devices will continue to witness robust demand and dominate the home diagnostics market with over than 80% revenue share in the market. According to the World Health Organization (WHO), the number of people suffering from diabetes reached 422 million in 2014, and it will soon become a leading cause of death. Increasing prevalence of diabetes worldwide and the growing need for monitoring sugar levels among diabetes patients is likely to boost adoption of glucose monitoring devices during the assessment period. Home diagnostics market players are aware of the surging demand for glucose monitoring devices, and are focusing on increasing their product portfolio in this segment. The other lucrative segments in the home diagnostics market include pregnancy tests and ovulation prediction kits.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=1892

According to the report, although demand for home diagnostics is concentrated in developed countries, home diagnostics market players are putting efforts to boost uptake in developing regions. According to statistics published by WHO, the prevalence of diabetes has been the highest in middle and low-income countries.

Anticipating the burgeoning demand for glucose monitoring devices in emerging Asia, players in the home diagnostics market are shifting their focus towards developing nations, including China and India. ARKRAY, Inc. – a Japanese manufacturer in the home diagnostics market – recently announced that it will strengthen its diabetes testing instrument production capacity in China. Leading manufacturers in the home diagnostics market are modifying their marketing strategies to improve awareness about cost-effective and efficient home diagnostics to leverage lucrative opportunities in the Asia-Pacific region.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags at home diagnostics market, cholesterol test kits, diagnostic services, digital home diagnostics, drug abuse test kits, glucose monitoring devices, HIV test kits, home diagnostics manufacturers, Home Diagnostics Market, home diagnostics market stakeholders, ovulation prediction test kits, pregnancy tests, self-diagnosis tests, US home diagnostics, vitro diagnosis tests, vitro diagnostics

Pharmaceutical

North America Dominates the Broth Dilution Method of Antimicrobial Susceptibility Test Market By 2025

Post author By administrator
Post date August 12, 2021

Fact.MR, the antimicrobial susceptibility test market is projected to record year-over-year growth of 6.5% in 2020, over 2019.

Opportunities for players in the antimicrobial susceptibility test market are likely to arise from increasing public-private partnerships in the healthcare sector. These partnerships are intended to encourage the free flow of finance for the development of effective products. Despite this financial lucidity, the high development cost of testing kits, given the complexity and tedious nature of testing, could adversely impact returns on investment of manufacturers.

Diagnostic laboratories and hospitals are projected to remain crucial end users, and a substantial chunk of product sales will close from the clinical diagnosis of bacteria, fungi, and parasites.

Click HERE To get a SAMPLE PDF (Including Full TOC, Table & Figures) at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4334

Key Highlights of Antimicrobial Susceptibility Test Market Study

Ease of sample processing through the use of advanced lab instruments and better turnaround time of samples are projected to create a large patient pool for diagnosis, which, in turn, will amplify the demand for antimicrobial susceptibility test kits during the forecast period.
Online sales channels are emerging as an integral revenue stream for the antimicrobial susceptibility test market. These channels are being leveraged by key vendors to disseminate brand information and gain access to local markets.
Initiatives taken by central health authorities are projected to draw consumers’ attention towards the importance of antibiotics. For instance, WHO observes a week in November as World Antibiotic Awareness Week (WAAW), to inspire the best clinical practices among health workers and policymakers in order to control antibiotic resistance.
Introduction of advanced antimicrobial susceptibility tests, which offer results in around 2 hours, sets the standards for better patient outcomes. For instance, FASTinov announced the launch of a rapid antimicrobial susceptibility test, which is based on flow cytometry, to offer clinically-implementable results in as little as two hours. Such advancements are likely to inspire the development of effective test products.

Antimicrobial Susceptibility Test Market – Assessment of Key Segments

Authors of the report have segmented the antimicrobial susceptibility test market into key categories in order to study the market at a microscopic level. The key segments considered while bifurcating the antimicrobial susceptibility test market include:

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4334

A senior market research analyst at Fact.MR opines that– “An entry into the antimicrobial susceptibility test market is highly capital-intensive, as CAPEX includes the cost of sophisticated equipment and skilled labor. In addition, capital becomes an essential fuel to foster R&D activities, which could create an entry barrier for new players in the antimicrobial susceptibility test market.”

Product	Method	Test Type	Application	End User	Region
Kits, Reagents, & Consumables	Broth Dilution Method	Antibacterial	Clinical Diagnosis	Diagnostic Laboratories and Hospitals	North America
Automated Test Systems	Rapid Automated Method	Antiparasitic	Drug Discovery and Development	Research and Academic Institutes	Latin America
Culture Media	Disk Diffusion Method	Antifungal	Others	Pharmaceutical and Biotechnology Companies	Europe
	Gradient Diffusion Method	Others		Contract Research Organizations	Asia Pacific
	Molecular Testing Method				Middle East & Africa

Besides laying focus on the aforementioned key segments, the report also studies the antimicrobial susceptibility test market at a country level, to recalibrate the underlying opportunities available for players in the antimicrobial susceptibility test market for the forecast period. Among all the estimated data, the report also includes Y-o-Y growth projections, which can help market players in comprehending the precise trajectory at which the antimicrobial susceptibility test market has been growing.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4334

Key companies profiled in the report on antimicrobial susceptibility test market include bioMérieux SA, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Alifax Holding S.p.A., Creative Diagnostics, Becton, Dickinson and Company, HiMedia Laboratories, Cepheid, Biotron Healthcare, and Conda.

Antimicrobial Susceptibility Test Market – Research Methodology

The antimicrobial susceptibility test market has been evaluated by taking a top-down and bottom-up approach. Demand, geographical presence, distribution strategies by manufacturers, and initiatives taken by governments and NGOs are various factors considered while estimating the revenue of the antimicrobial susceptibility test market for each device, and thus, reaching global numbers. The study on the antimicrobial susceptibility test market is further validated through extensive primary research on the data extracted from exhaustive secondary research.

In order to conduct secondary research, annual company reports, company websites, data from the World Health Organization (WHO), SEC filings, press releases, investor presentations, and other similar resources were studied. To validate the information compiled through secondary research, interviews with key opinion leaders and subject matter experts were scheduled. In addition to this, authors of the report also had email and telephonic interactions with the senior management of leading and prominent companies to confirm the size, growth trends, and future outlook of the antimicrobial susceptibility test market.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Antimicrobial Susceptibility diagnostics, Antimicrobial Susceptibility Test, Antimicrobial Susceptibility Test Market, Antimicrobial Susceptibility Test Market size

Pharmaceutical

High Demand for 0.2T Systems to Reflect the Growing Need for Low-field Intraoperative MRI Equipment

Post author By administrator
Post date August 12, 2021

Traditional image-guided procedures remained restricted to the limitation of physicians referring to pre- and post-operative images for conducting neurosurgical or maxillofacial procedures. With advancements in medical imaging technologies, intraoperative MRI techniques paved their way in the diagnosis-guided surgery landscape, enabling physicians and surgeons to view the images during surgery, rather than referring to them preoperatively or postoperatively. Advanced intraoperative MRI equipment are being developed to facilitate enhanced imaging for physicians and lower the risks of improper surgeries during preoperative conditions.

Fact.MR observes as robust growth in demand for intraoperative MRI equipment in the global healthcare marketplace. By the end of 2026, the global intraoperative MRI equipment market is estimated to surpass US$ 315 million valuation. The advantage of intraoperative MRI equipment in improving the localization for physicians during surgeries will continue to bolster their demand in the near future. During the period, 2017-2026, the global market for intraoperative MRI equipment is assessed to reflect a CAGR of 7.1% in terms of volume.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=519

The Uptake for Intraoperative MRI Equipment to Remain High in Medical Communities

As the years progress, advancements in medical imaging technologies are being welcomed by communities of physicians and surgeons across the globe. Currently, the adoption of intraoperative MRI equipment showcases a promising growth. Leading medical research organizations are exhibiting readiness to invest in technologies for instrumenting developments in the operability and functioning of intraoperative MRI equipment. Multiple advantages of using intraoperative MRI equipment will be driving their uptake in the coming years.

Real-time visualization offered by latest intraoperative MRI equipment to improve the efficiency of surgical interventions
Gradient-imaging advantage of intraoperative MRI equipment to support physicians in planning the path of surgery
Cost-effective maintenance to compensate for high prices of intraoperative MRI equipment
The co-efficiency of intraoperative MRI equipment in lowering the chances of second surgical intervention to aid patient outcomes of hospitals

Global Intraoperative MRI Equipment Market: Segmentation

Product Type	0.2T System 1.5T System 3.0T System Others
End User	Hospitals Cancer Research Institutes Academic Institutes Other End Users
Application	Neurosurgical Intervention Orthopedic Procedures Cardiovascular Intervention Other Applications

Following Questions Answers Covered in the Report are:

How will the global Intraoperative MRI Equipment Market perform during the forecast period? What will be the market size in terms of value and volume?
Which segment will drive the global Intraoperative MRI Equipment Market? Which regional market will show extensive growth in the future? What are the reasons?
How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
What are the key strategies adopted by players to sustain themselves in the global Intraoperative MRI Equipment Market?
How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=519

Prominent Players

GE Healthcare
Medtronic Plc
Siemens AG
IMRIS Inc.
Koninklijke Philips N.V.
Hitachi Corporation

Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/osteoporosis-testing-market-growth-spurred-by-surging-cases-of-osteoporosis-says-fact-mr

Neurosurgical Interventions to Represent Highly-Profitable Applications of Intraoperative MRI Equipment

Considering the significance of obtaining quality outcomes during neurosurgeries, advanced equipment are being used across hospitals in the world. Intraoperative MRI equipment are an addition to the range of devices used during neurosurgical intervention. By the end of 2026, more than 1,640 units of intraoperative MRI equipment will be adopted for neurosurgical intervention applications around the world. The report also estimates that orthopedic procedures will represent a fast-growing application of intraoperative MRI equipment during the forecast period.

North America – Largest Market for Intraoperative MRI Equipment through 2026

The report estimates that majority of intraoperative MRI equipment are produced and sold in the US. High value growth in North America’s medical tourism sector will drive the sales of intraoperative MRI equipment in the US and Canada. Companies such as Medtronic Plc, GE Healthcare, IMRIS, Inc., Siemens AG, Hitachi Corporation, and Koninklijke Philips N.V., which are the key players in global intraoperative MRI equipment market are prominent in the US and have gained their footholds across Europe and the Asia-Pacific excluding Japan (APEJ) region.

In the coming years, a steady demand for 0.2T systems will be observed in the global intraoperative MRI equipment landscape. Growing need for low-field MRI in surgical interventions will drive the demand for 0.2T systems across the globe. The report also estimates that 3.0T systems will register a rapid growth in terms of volume, reflecting a 9% CAGR over the forecast period. Manufacturers will continue to extend the production of these two key systems to capture the specific demands of physicians. Moreover, lowering the risks of these systems in creating geometrical distortion will be prioritized by intraoperative MRI equipment manufacturers in the foreseeable future.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=519

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Press Release:https://www.factmr.com/media-release/444/intraoperative-mri-equipment-market

Tags Intraoperative MRI Equipment demand, Intraoperative MRI Equipment Market, Intraoperative MRI Equipment Market analysis, Intraoperative MRI Equipment Market Insight, Intraoperative MRI Equipment Market intelligence, Intraoperative MRI Equipment Market report, Intraoperative MRI Equipment Market research surveys, Intraoperative MRI Equipment Market share, Intraoperative MRI Equipment Market size, Intraoperative MRI Equipment Market strategy, Intraoperative MRI Equipment Market survey, Intraoperative MRI Equipment Market trends

Pharmaceutical

Demand for Neonatal Brain Monitoring Equipment Gain High Traction In the Near Future: Fact.MR

Post author By administrator
Post date August 12, 2021

Recent Fact.MR report envisages the demand for neonatal monitoring equipment to record a steady 5.7% CAGR during the forecast period (2018-2028). Over 1,070,000 neonatal monitoring equipment are pegged to be sold worldwide by 2028-end.

Increased interest of neonatal monitoring equipment manufacturers in providing technologically-integrated and high-end solutions mirrors the healthcare sector’s inclination toward value-based care. Innovative technology offerings of new neonatal monitoring equipment manufacturers coupled with their attractive pricing has compelled major companies in expanding their product portfolio for meeting the requirement of neonatal intensive care units (NICUs).

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=746

key segments:Neonatal Monitoring Equipment Market

The report has branched the neonatal monitoring equipment market in terms of product type, modality, end-user, and region.

Based on product type, key segments include,

Ventilator
Pulse Oximeter
Capnography Meter
Cardiorespiratory Monitor
Bilirubinometer
EEG Monitor
Blood Pressure Monitor

Based on modality, key segments include,

Portable Devices
Transportable Devices
Standalone Devices

Based on end-user, key segments include,

Hospitals
Neonatal Clinics
Nursing Homes
Diagnostic Centers
Other End-Users

Following Questions Answers Covered in the Report are:

How will the global Neonatal Monitoring Equipment Market perform during the forecast period? What will be the market size in terms of value and volume?
Which segment will drive the global Neonatal Monitoring Equipment Market? Which regional market will show extensive growth in the future? What are the reasons?
How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
What are the key strategies adopted by players to sustain themselves in the global Neonatal Monitoring Equipment Market?
How will these strategies influence the market growth and competition?

Full Access of this Report Is Available At https://www.factmr.com/checkout/746

Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/investments-to-improve-cancer-treatments-and-therapeutics-is-helping-development-of-peritoneal-cancer-treatment-market/

Neonatal Monitoring Equipment Market: North America Continues to Stay at Vanguard with High Focus on Palliative Care

North America continues to stay at the vanguard of the neonatal monitoring equipment market, with an estimated market value share of over one-third through the period of forecast. Rate of premature birth has been steadily rising in North America over the past couple of years, according to the CDC, which in turn has increased the number of NICU admissions, thereby creating demand for neonatal monitoring equipment.

Speciality of hospice and palliative medicine has gained significant recognition in North America, with attendant increase in training programs at both academic and clinical level. The imperative role of palliative care in improving growth development outcomes in newborn babies has been highly recognized in the region’s NICUs for reducing the infant and neonatal mortality rates.

Neonatal Monitoring Equipment Market: Ventilators Continue to Hold Bulk Value Shares

Ventilators are set to prevail as preferred product among end-users of neonatal monitoring equipment, and will continues to account for bulk value shares of the market. Recent FDA approvals of new, patient-triggered ventilators, and neurally-adjusted ventilator assist (NAVA), for non-invasive and invasive ventilation related to neonates will augur well for sales of ventilators in the forthcoming years. Additionally, availability of several ventilation modes and strategies for assisting ventilation optimization, and preventing ventilation-induced lung injury will fuel ventilator sales.

Standalone modality of neonatal monitoring equipment will continue to spearhead the market in terms of value share. This is mainly because standalone devices enable clinicians in offering care delivery even while the hospital’s electronic medical records are in their downtime. However, relatively faster sales expansion has been foreseen for portable neonatal monitoring equipment through 2028.

Manufacturers are offering cost-effective portable neonatal monitoring equipment that enable uninterrupted monitoring at the bedside and during in-hospital transport. Growing development of easy-to-use, compact and light portable devices will further fuel their sales in the upcoming years.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=746

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Press Release:https://www.factmr.com/media-release/479/neonatal-monitoring-equipment-market

Tags Neonatal Monitoring Equipment Market analysis, Neonatal Monitoring Equipment Market Insight, Neonatal Monitoring Equipment Market intelligence, Neonatal Monitoring Equipment Market report, Neonatal Monitoring Equipment Market research report, Neonatal Monitoring Equipment Market research surveys, Neonatal Monitoring Equipment Market share, Neonatal Monitoring Equipment Market size, Neonatal Monitoring Equipment Market strategy, Neonatal Monitoring Equipment Market survey, Neonatal Monitoring Equipment Market trends

Pharmaceutical

Spine Devices Market is projected to reach US$ 8,348.2 Million revenue by the end of 2022

Post author By administrator
Post date August 12, 2021

Low back pain is becoming a very common health problem across the globe. Affecting people of all ages from children to elderly, low back pain can be acute or chronic. The prevalence of spine disease is also on a rise due to increasing aging population, changing lifestyle, constant stress, acute or repetitive injuries and various other conditions. There has been a drastic change in spine surgery, with the robotic spine surgery currently being offered by few healthcare providers, giving patients improved outcome than the traditional surgical procedure.

Manufacturers are also focusing on developing minimally invasive devices. As the less invasive procedure can result in lower pain score and lead to quick recovery time. Surgeons around the world are also focusing on endoscopic techniques leading to less invasive spine care, hence, new technologies are being developed to simplify technically complex procedures. Spine device market manufacturers are also working towards offering better spinal imaging technology for sharper images. Effective in chronic pain conditions, spinal cord stimulation therapy is on a rise, hence, manufacturers are developing spinal cord stimulator devices that can reduce the risk of thermal tissue damage and are compatible with MRI.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=259

Hospitals to Witness Maximum Revenue Share

Hospitals are expected to form as strong customer base in the spine devices market as compared to orthopedic clinics. Towards the end of 2017, hospitals are anticipated to account for over two-third revenue share of spine devices market. Hospitals as end users are projected to reach close to US$ 5,700 million by the end of 2022. Increasing number of spinal surgeries performed at hospitals is one of the factors driving expansion of spine devices market.

global spine devices market

Companies are also working on stem cell technology and its use in the spine. According to the latest report by Fact.MR, the global spine devices market is expected to witness massive growth, registering 7.1% CAGR during the forecast period, 2017 to 2022. Owing to an aging population, occupational posture, obesity, etc., spinal diseases are growing rapidly. Hence, spine surgery has also undergone a significant change, with new spine devices being developed to decompress and stabilize the spine. Following insights show how the global spine devices market will perform in the next five years.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=259

4 Key Insights on Global Spine Devices Market

1. North America is projected to remain dominant in the global spine devices market throughout the forecast period from 2017 to 2022. The market is anticipated to witness the robust growth, reaching close to US$ 2,900 million revenues by the end of 2022. Owing to the availability of healthcare infrastructure and increase in investment by the government to improve healthcare across the region, North America is expected to emerge as the biggest market for spine devices.

2. Asia Pacific Excluding Japan (APEJ) spine devices market is expected to experience impressive growth through 2022. The rise in a number of accidents resulting in spine injury, improving lifestyle and an aging population are some of the factors boosting the growth of APEJ spine devices market.

3. Spinal plates will emerge as one of the most-preferred spine devices. Towards the end of 2017, Spinal plates are projected to gain nearly one-fourth of the revenue share. Meanwhile, spinal screws will also witness healthy growth, reaching nearly US$ 1,500 million revenue by 2022 end.

4. Compared to orthopedic clinics as the end user of spine devices, hospitals will emerge as the biggest users of spine devices. Towards the end of 2022, Hospitals as the end user are projected to surpass US$ 5,600 million revenue. Hospitals are also expected to account for more than two-third revenue share on global revenues by the end of 2017.

Get More Insights-https://www.prnewswire.com/news-releases/us-3-billion-opportunity-emerging-in-spine-devices-market-fact-mr-study-894181246.html

The report has also profiled leading players in the global market for spine devices, which will remain active through 2022. These include companies such as NuVasive, Inc., Exactech, Inc., DePuy Synthes, Braun Melsungen AG., Amedica Corporation, Arthrocare, K2M Group Holding, Inc., Medtronic Plc., Zimmer Biomet Holdings, Inc., and Stryker Corporation.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/259/spine-devices-market
Press Release: https://www.factmr.com/media-release/248/spine-devices-market
Follow Us: LinkedIn | Twitter

Tags Spine Devices Demand, Spine Devices Market, Spine Devices Market Forecast, Spine Devices Market Growth, Spine Devices Market Insights, Spine Devices Market Report, Spine Devices Market size, Spine Devices Market Survey, Spine Devices Market Trends

Pharmaceutical

MRI-guided Radiation Therapy Systems Market is projected to record a CAGR of approximately 20% through 2028

Post author By administrator
Post date August 12, 2021

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR. This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.

The study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree. In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=2572

“Leading cancer research institutes are exploring the potential for MRI in radiation therapy in order to enhance the efficiency and precision of existing cancer treatments. However, integrating MRI technology, which uses magnetic field to produce images, with an all-metal linear accelerator in radiation therapy devices requires exceptional technological expertise and a strong international consortium. Currently, Elekta and Viewray are the only two companies that have a strong foothold in the MRI-guided radiation therapy systems market, and it may be a while until new entrants make foray into the market,” says Fact.MR.

Hospitals Remain the Target Customers for Market Players

The study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019. Opportunities abound for of MRI-guided radiation therapy system developers,, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT (Linear accelerators integrated with magnetic resonance radiotherapy).

The study also finds that radiotherapy centers are adopting technologically-advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective. Market players are focusing on building a successful consortium with the help of physicians, clinicians, as well as Original Equipment Manufacturers (OEMs), to tap opportunities in the radiation therapy centers.

The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America. In 2017, the per capita health expenditure was over US$10,000 in the U.S., recording an increase of nearly 4% over 2016, according to studies. In addition, an alarming rise in the prevalence of cancer in the U.S. will reflect in a significant demand for MRI-guided radiation therapy systems in North America.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=2572

According to the study, North America accounted for 45% sales of MRI-guided radiation therapy systems in 2018. Healthcare organizations in the region are investing heavily in tech-driven radiation treatments for cancer. While demand remains robust in developed markets, developing economies are also emerging as attractive markets for MRI-guided radiation therapy systems. Increasing government investments in healthcare infrastructure in the region, are expected to create new opportunities for the players in the MRI-guided radiation therapy systems market.

The study offers comprehensive outlook of the MRI-guided radiation therapy systems market for the period, 2018 to 2028. The MRI-guided radiation therapy systems market is projected to record a CAGR of approximately 20% through 2028.

Competitive Landscape

The only two MRI-guided radiation therapy systems manufacturers are Elekta AB, Viewray technologies, Inc. The market is still in its early days and thus there are not many market players. Their main focus is on developing MRI compatible modern radiation therapy system with no interference between two components. Development of such innovative products requires huge capital investment and extensive research. These two companies heavily rely on patenting and product licensing for revenue generation.

Get More insights- https://www.biospace.com/article/rising-demand-for-innovative-cancer-treatment-options-boosts-mri-guided-radiation-therapy-systems-demand-fact-mr/

Elekta AB is working towards building FDA approved products and capture maximum market shares in North America. Viweray technologies Inc made strategic collaboration with Minogue Medical Inc. and Device Technologies Australia Pvt Ltd to expand their market in Canada, Australia and New Zealand.

More Insights on the MRI-Guided Radiation Therapy Systems Market

In its latest report, Fact.MR offers unbiased analysis of MRI-guided radiation therapy systems market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (Linac MR-RT system, software), MR dimension (0.5 Tesla MR Scanner, 1.5 Tesla MR Scanner) and end user (hospital, Radiotherapy centers, Cancer research institutes) across six regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

Explore Fact.MR’s Coverage on the Biospace Domain

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/2572/mri-guided-radiation-therapy-system-market
Press Release: https://www.factmr.com/media-release/1004/global-mri-guided-radiation-therapy-system-market
Follow Us: LinkedIn | Twitter

Tags MRI-guided Radiation Therapy System Market, MRI-guided Radiation Therapy System Market Forecast, MRI-guided Radiation Therapy System Market Growth, MRI-guided Radiation Therapy System Market Insight, MRI-guided Radiation Therapy System Market Report, MRI-guided Radiation Therapy System Market Share, MRI-guided Radiation Therapy System Market Size, MRI-guided Radiation Therapy System Market Survey, MRI-guided Radiation Therapy System Market Trends

Pharmaceutical

Antibiotic Residue Test Kits Market worth US$ 295 Million by 2026 – Exclusive Report by Fact.MR

Post author By administrator
Post date August 12, 2021

Key role of simple diagnostic tests in detecting the presence of antibiotic residues in foods derived from animals will continue to propel the demand for antibiotic residue test kits. These tests ensure the food is safe for human consumption. Findings from these tests are of great value in increasing the nutritional index of animal-based foods. Moreover, stringent food safety measures continue to necessitate the need for adopting antibiotic residue test kits in the food & beverage industry.

Fact.MR’s recent report estimates the expansion of the global demand for antibiotic residue test kits for the period, 2021-2026. During this forecast period, the global antibiotic residue test kits market is expected to witness growth at 6.2% CAGR in terms of value. By the end of 2026, around US$ 295 Mn worth of antibiotic residue test kits are expected to be sold globally.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=496

4 Key Highlights from the Report

1- According to the report, the adoption of beta-lactams tests will be the highest across the global antibiotic residue test kits market. The report observes that throughout the forecast period, sales of beta-lactams tests will account for approximately one-third share of global market revenues. By the end of 2026, nearly US$ 95 Mn worth of beta-lactams test kits will be sold globally. The demand for tetracycline tests will also gain traction in the upcoming years, bringing in around US$ 50 Mn in global revenues by the end of 2026. Meanwhile, sulfonamides tests will register fastest revenue growth at a CAGR of 7.1% over the forecast period.

2- Food and beverage industry will represent the largest end-user of antibiotic residue test kits. More than 65% of the global antibiotic residue test kits market value will be accounted by the end-use of these kits in ensuring the safety of food items and beverages, particularly for dairy products. The report also observes a rampant end-use of antibiotic residue test kits in veterinary purposes.

3- In 2017, North America registered highest sales of antibiotic residue test kits. The consumer marketplaces in the US and Canada will continue to promote the use of antibiotic residue test kits in food safety measures. By the end of 2026, North America will be dubbed as the largest market for antibiotic residue test kits, surpassing an estimated valuation of US$ 100 Mn.

4- Europe and the Asia-Pacific excluding Japan (APEJ) regions are also expected to be at the forefront of global antibiotic residue test kits market expansion. These two region will register fast revenue growth in their antibiotic residue test kits markets, particularly due to high presence of dairy product manufacturers.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=496

The report has profiled key companies developing antibiotic residue test kits across the globe. Companies namely, are observed as Thermo Fisher Scientific, Charm Sciences, DSM, Labtek Services Ltd., Perkin Elmer (Bio Scientific Corp.), IDEXX Labs, Neogen Food Safety, R-Biopharm AG, Sciex, and Eurofins are observed as key players in the global antibiotic residue test kits market. Majority of these players will be incorporating the advancements in the diagnostics of antibiotic residues. Extending the application of antibiotic residue test kits beyond measuring the safety of animal-based foods will also be prioritized by these companies in the near future.

Food & Beverage Industry End-use to Translate High Revenue Growth

In 2018 and beyond, antibiotic residue test kits will be predominantly used in the food and beverage industry.

A range of antibiotic residue test kits are being used for ensuring safety of milk and other dairy products.

Their use in inhibiting the growth of microorganisms through anti-infection principles will further extend their end-use in the global production of food items and beverages.

By the end of 2026, the end-use of antibiotic residue test kits in global food & beverage industry will bring in revenues worth over US$ 196 Mn.

The report also reveals that the veterinary end-use of antibiotic residue test kits will register fastest revenue growth at an estimated 6.7% CAGR over the forecast period.

Get More Insights- https://www.biospace.com/article/antibiotic-residue-test-kits-market-gaining-traction-as-a-food-safety-measure-fact-mr/

More Insights on the Antibiotic Residue Test Kits Market

In its latest report, Fact.MR offers unbiased analysis of the global antibiotic residue test kits market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of test type (beta-lactams, macrolides, tetracycline, Amino-glycosides, Amphenicols, and Sulfonamides) and end user (food and beverages industry, veterinary, and independent laboratory) across six regions (North America, Latin America, Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Paper Based Diagnostic Test Kits Market: A recent study by Fact.MR on the paper based diagnostic test kits market offers a 10-year forecast analysis for the period 2017 to 2027. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Direct Fluorescent Antibody Test Kits: Fact. MR’s extensive coverage on the direct fluorescent antibody test kits market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Ready-to-use Laboratory Test Kits: The global ready-to-use laboratory test kits market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/496/antibiotic-residue-test-kits-market
Press Release: https://www.factmr.com/media-release/427/antibiotic-residue-test-kits-market
Follow Us: LinkedIn | Twitter

Tags Antibiotic Residue Test Kits demands, Antibiotic Residue Test Kits Market analysis, Antibiotic Residue Test Kits Market Insight, Antibiotic Residue Test Kits Market intelligence, Antibiotic Residue Test Kits Market report, Antibiotic Residue Test Kits Market research report, Antibiotic Residue Test Kits Market share, Antibiotic Residue Test Kits Market size, Antibiotic Residue Test Kits Market strategy, Antibiotic Residue Test Kits Market survey, Antibiotic Residue Test Kits Market trends

Pharmaceutical

MRI Safe Implantable Defibrillator Devices Market: Booming Demand from Emerging Economies to Market Growth Globally

Post author By administrator
Post date August 11, 2021

Fact.MR has recently published a report, titled [Global MRI Safe Implantable Defibrillator Devices Market 2020 by Key Countries, Companies, Type and Application]. The research report provides an in-depth explanation of the various factors that are likely to drive the market. It discusses the future of the market by studying the historical details. Analysts have studied the ever-changing market dynamics to evaluate their impact on the overall market. In addition, the report also discusses the segments present in the market. Primary and secondary research methodologies have been used to provide the readers with an accurate and precise understanding of the overall The MRI Safe Implantable Defibrillator Devices market. Analysts have also given readers an unbiased opinion about the direction companies will take during the forecast period.

The global demand for MRI safe implantable defibrillator devices witnessed a slight fall in the first quarter of 2020 due to the spread of Covid-19 pandemic. Major attention was shifted towards preventing the ongoing crisis leading to neglecting further developments in this market. However, as the cases are getting down in 2021, incessant efforts of the market players are helping themto recuperate their market position.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=566

MRI Safe Implantable Defibrillator Devices Market: Drivers & Restraints

Several product advancements, rising geriatric population, increase in cardiac diseases and number of eligible population are some of the factors supporting the market growth of MRI safe implantable defibrillator devices. Furthermore, rising evidence about safety of these systems and effective marketing campaigns by various manufacturers supports the market growth of MRI safe implantable defibrillator devices. However, high product pricing and stringent regulatory issues for product approval lowers its market growth over the forecast period. Reimbursement issues, lack of skilled professionals in several countries are also limiting the market progress.

MRI Safe Implantable Defibrillator Devices Market: Segmentation
Segmentation by Product Type:
Single Chamber Defibrillator
Dual Chamber Defibrillator

Segmentation by Modality:

MR Conditional Defibrillator
MR Safe Defibrillator

Segmentation by End User

Hospitals
Ambulatory Surgical Centers

MRI Safe Implantable Defibrillator Devices Market: Overview
There are very few companies involved in the manufacturing of devices with MRI compatibility. The products are launched in the market only few years back. Medtronic announced the CE Mark and European launch of first MRI safe implantable defibrillator devices to allow for full-body MRI Scans in April 2014. USFDA has also approved the first MRI compatible ICD manufactured by Medtronic recently in September 2015. Despite the launch of MRI safe implantable defibrillator devices, most of the population is still present with the non-MRI compatible devices.

Companies in this direction are investing on research and development activities for advancement in these device types to improve therapy outcomes and manufacturing of low cost MRI safe implantable defibrillator devices. Top 3 companies in this market represent most of the market share globally for these MRI safe implantable defibrillator devices due to their strong presence, product approvals, brand strength and lack of competitors.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=566

MRI Safe Implantable Defibrillator Devices Market Treatment Market: Key Players
Some of the players in the MRI Safe Implantable Defibrillator Devices market includes Medtronic, Boston Scientific Corporation, Abbott, Microport, Biotronik etc.

The MRI Safe Implantable Defibrillator Devices market report addresses the below-mentioned queries:

Why are vendors shifting away from traditional methods of manufacturing MRI Safe Implantable Defibrillator Devices?
How does the global MRI Safe Implantable Defibrillator Devices market looks like in the next five years?
Which end use industry is expected to surpass segment by the end of Forecasted period?
What innovative products are being introduced by the players in the global MRI Safe Implantable Defibrillator Devices market?
Which regions are showing the fastest market growth?

Crucial insights in the MRI Safe Implantable Defibrillator Devices market research:

Underlying macro- and microeconomic factors impacting the growth of the market.
Basic overview of the MRI Safe Implantable Defibrillator Devices, including market definition, classification, and applications.
Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
Adoption trend of MRI Safe Implantable Defibrillator Devices across various industries.
Important regions and countries offering lucrative opportunities to market stakeholders.

Explore Fact.MR’s Coverage on the Healthcare Domain
Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Pharmaceutical

Global Lab Workflow Solutions Market Is Anticipated To Gather Pace In Lucrative Regions Such As North America And Asia Pacific

Post author By administrator
Post date August 11, 2021

The global Lab Workflow Solutions market is projected to show healthy growth during the forecast period of 2021-2031, finds Fact.MR in this study. Increasing burden from regulatory authorities for lab automation will create lucrative growth opportunities for the market.

The demand of lab workflow solutions market is anticipated to gather pace in lucrative regions such as North America and Asia Pacific. Expected to secure a larger share of the market in the near future, the developed region could bank on high digital literacy, better infrastructure, and the availability of policies supporting the deployment of laboratory information systems. Increasing pressure to end cost curve could result in high adoption of lab workflow solutions in the region. High number of pharmaceutical companies operating and increasing lab operational cost could be other reasons for increased demand for lab workflow solutions in the region.

To get in-depth insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=436

Dependency for Regulating Routine Lab Workflows Stimulating Sales of Lab Workflow Solutions
With greater dependency on sample testing in the in-vitro space in healthcare domain, it has become essential to regulate and streamline day-to-day sample processing in laboratories. With that as a primary focus of various laboratories, the essentiality of lab workflow solutions has never been so imperative than it is today. This is massively pushing the adoption of various lab workflow solutions such as software and analytics to restructure and rationalize the sample data collected in labs, which is driving the growth of lab workflow solutions market.

In the era of IT implementation, changing reimbursement landscape and healthcare integration, improvements in lab workflow solutions should not be confined to laboratory success alone but should extend to various departments thus leveraging improvement opportunities across healthcare organizations.

Lab Workflow Solutions Market- Restraints
Higher capital cost and unclear regulatory guidelines for medical application is likely to impede the growth of lab workflow solutions market. Higher cost of lab workflow solutions instrument is a major factor hampering its adoption across resource-poor countries. The overall cost of lab workflow solutions’ implementation would be beyond budget for some medium scale laboratories. Moreover, higher maintenance costs associated with DP installations and costlier training and development programs for end users are other factors likely to restrain the growth of lab workflow solutions market.

Lack of awareness regarding lab workflow solution systems and cloud-enabled technologies, especially in developing economies such as China and India, is restraining growth of the market. This is ultimately increasing the cost of on-premise platforms, which in turn increases total expenditure on lab workflow solutions technology. Such rising capital expenditure on hardware and storage is reducing the adoption of lab workflow solution, thereby hampering the market growth.

Empowering Diagnostics with Lab Workflow Solutions
With increasing complexity in diagnostic laboratories, the need for critical management to ensure balance between financial and operational priorities including managing personnel, budgets, customer satisfaction and quality assurance has become vital in diagnostic laboratories. With advanced lab workflow solutions, diagnostics can be taken to a next level using a holistic approach to facilitate speed, cost reductions and quality, consequently enabling efficient implementation, laboratory benchmarking and overall lab workflow.

Share Your Requirements & Get Customized Reports https://www.factmr.com/connectus/sample?flag=RC&rep_id=436

Lab Workflow Solutions Market- Key Companies
Perkin Elmer, Inc., GE Healthcare, Definiens AG, Koninklijke Philips N.V, Sectra ABss, Ventana Medical Systems, Inc., 3D-Histech Ltd, Inspirata Co., Leica Biosystems, Quorum Technologies Inc., Hamamatsu Photonics, K.K., Yokogawa Electronic Corporation, Digipath Co., Olympus Corporation and ZEISS are some of the key companies which provide lab workflow solutions across the globe.

Lab Workflow Solutions Market- Drivers
Growing demand for laboratory services has increased the importance of lab workflow solutions over the past few years. The lab industry has witnessed a significant transitions in terms of sample processing. These in-vitro diagnostic technologies have increased the pace of lab services. However, limitation in terms of sample processing and availability of skilled work force in the lab space have reduced the efficacy of lab services. The lab workflow solution market is emerging as a novel solution to these problems. Presently, lab workflow solutions are reasonably dominant in the research and development sector. Going forward, they are likely to be established as a one of the key components in lab industry, owing to their promising attributes over conventional lab techniques.

The lab workflow solutions market is being shaped by the collaborative approach between pathology laboratories and research centers with cloud service providers. This is expected to increase awareness regarding lab workflow solution technology, and also provide new platforms to end users, thereby fuelling the growth of lab workflow solutions market.

Regional Segments Analyzed Include

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

Explore Fact.MR’s Coverage on the Healthcare Domain –
Lab Automation Market– Fact.MR in its latest report has an in-depth analysis that examines the global sales of lab automation equipment and software in 20+ high-growth markets, as well as the influence of COVID-19 on the healthcare business in general and lab automation demand in particular.

Lab Workflow Solutions Market– Due to national mandated lockdown and social distance enacted in 2020, global demand for lab workflow solutions decreased slightly during the Covid-19 pandemic. In 2021, there will be a strong preference for lab workflow solutions due to the growing need for standardized procedures in clinical laboratories such as sample receipts, handlings, and preparation of lab samples, guidance for assay data collection, and the reduction of potential errors.

Ready-to-use Laboratory Test Kits Market– Healthcare providers are increasingly requesting ready-to-use laboratory test kits since they give innovative solutions as well as technical assistance. The ready-to-use laboratory test kits are accurate, simple to use, and enable for rapid diagnosis of a wide range of infectious disorders.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Pharmaceutical

Interventional ENT devices are increasingly adopted due to the cosmetic advancements in the healthcare sector

Post author By administrator
Post date August 11, 2021

The spread of Covid-19 pandemic declined the global sales of interventional ENT devices in 2020 leading to slowdown in its market progress. Due to economic slowdown, the government lifted up all the restrictions and allowed manufacturing companies to start back their operations.

The Ester Gum industry will see significant growth and a robust CAGR over the forecast period. According to the latest research report by Verified Market Research, the development of the Interventional ENT Devices Market is mainly supported by a sharp increase in demand for products and services in this industry. A detailed summary of Interventional ENT Devices Market valuation, sales estimate, and market stats is an important part of the report. Hence, the aim of the report is to help readers gain viable insights into the competitive spectrum of the Interventional ENT Devices Market. It also draws attention to the important business expansion strategies pursued by the major competitors in the market in order to strengthen their position in the world market.

For detailed insights on enhancing your product footprint, request for a sample here: https://www.factmr.com/connectus/sample?flag=B&rep_id=978

Competitive Landscape
The report presents the business mechanisms and growth-oriented approaches of leading companies operating in this Interventional ENT Devices Market. The report highlights the numerous strategic initiatives such as new deals and collaborations, mergers and acquisitions, joint ventures, product launches, and technology upgrades being implemented by leading market competitors to gain a foothold in the marketplace. Therefore, this section contains the company profiles of the major players, the accumulation of total sales, product sales, profit margins, product prices, sales and distribution channels, and industry analyzes.

Interventional ENT Devices Market: Key Players
The global market for interventional ENT devices market is highly fragmented. Examples of some of the key players operating in the global interventional ENT devices market are Medtronic PLC, Karl STORZ GmbH & Co., Olympus Corporation, Stryker Corporation, Acclarent Inc., Sonova Holdings AG, Hoya Corporation, William Demant Holdings A/S and Cochlear Limited.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Interventional ENT Devices Market: Segmentation
Tentatively, the global Interventional ENT devices market can be segmented on the basis of treatment, end user and geography.
Based on Product Type, the global Interventional ENT devices market is segmented as:

Radiofrequency headpiece
Powered surgical instrument
Ontological drill burs
ENT hand instruments
Sinus dilation devices
Nasal packing devices
Tympanostomy tubes

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=978

Based on end user, the global Interventional ENT devices market is segmented as:

Hospital
Specialty clinic
Ambulatory surgical center

Geographical Analysis of the Interventional ENT Devices Market:
The latest Business Intelligence report analyzes the Interventional ENT Devices Market in terms of market size and consumer base in major market regions. The Interventional ENT Devices Market can be divided into North America, Asia Pacific, Europe, Latin America, Middle East and Africa based on geography. This section of the report carefully assesses the presence of the Interventional ENT Devices Market in key regions. It determines the market share, the market size, the sales contribution, the distribution network and the distribution channels of each regional segment.

Essential Takeaways from the this Market Report

Comparison of prominent players operating in the market.
Recent developments and key strategies adopted by key players.
Study of the micro and macro-economic growth indicators.
Impact of the various factors on the value chain.
Evaluation of current Interventional ENT Devices market size, forecast and technological advancements within the industry.
Current Insights influencing the scenario and key trends in Interventional ENT Devices market.

Geographic Segment Covered in the Report:

North America (USA and Canada)
Europe (UK, Germany, France and the rest of Europe)
Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
Latin America (Brazil, Mexico, and the rest of Latin America)
Middle East and Africa (GCC and rest of the Middle East and Africa)

Explore Fact.MR’s Coverage on the Healthcare Domain :
Diagnostic Imaging Services Market: The global diagnostic imaging services market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

Portable Dialysis Machines Market: Fact. MR’s extensive coverage on portable dialysis machines market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent Product Type and end users, along with important information concerning key manufacturers operating within the industry.

Bioabsorbable Osteosynthesis Devices Market: Bioabsorbable Osteosynthesis Devices Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2026

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Tags Interventional ENT Devices Market, Interventional ENT Devices Market Insight, Interventional ENT Devices Market report, Interventional ENT Devices Market share, Interventional ENT Devices Market size, Interventional ENT Devices Market Value